DuPont Pioneer Demonstrates Future Potential of New Insect Control
RNA interference discovery also demonstrating efficacy for protection from corn rootworms
DuPont Pioneer researchers have discovered a protein from a non-Bacillus thuringiensis (Bt) bacterium source that exhibits promise as an alternative means for controlling corn rootworm in North America and Europe. Science Magazine published the finding this week.
“This research represents a breakthrough for addressing a major challenge in agriculture,” said Neal Gutterson, vice president, Research & Development, DuPont Pioneer. “We have discovered a non-Bt protein that demonstrates insecticidal control of western corn rootworm with a new and different mode of action than Bt proteins currently used in transgenic products. This protein could be a critical component for managing corn rootworm disease in future corn seed product offerings. The work also suggests that bacteria other than Bt are alternative sources of insecticidal proteins for insect control trait development.”
An extremely destructive corn pest, corn rootworm larvae and adults can cause significant economic loss for growers. The current biotech approach for insect control sources proteins from Bt soil bacteria. Field-evolved insect resistance to certain Bt proteins has been observed in some geographies.
Another Pioneer study related to non-Bt insect control, recently published in Scientific Reports, shows how RNA interference (RNAi) can be applied to control corn rootworm feeding damage.
RNAi is a biologically occurring process that happens in the cells of plants, animals and people. By employing the RNAi process, a plant can protect itself by carrying instructions that precisely target specific proteins in pests.
“Growers need a next generation of solutions to help protect their crops. Our researchers are developing innovative, new modes for insect control to help meet future demands. Non-Bt proteins and RNA-based products highlight our efforts to identify alternative methods for effective control of insect feeding damage in agriculture,” Gutterson said.
Pioneer is committed to delivering superior germplasm, native and biotech traits, seed treatments and agronomic advice for the most productive products to its customers. Pioneer has a robust product pipeline. Maintaining trait durability and promoting world-class stewardship practices are among its top priorities
DuPont Pioneer is the world's leading developer and supplier of advanced plant genetics, providing high-quality seeds to farmers in more than 90 countries. Pioneer provides agronomic support and services to help increase farmer productivity and profitability and strives to develop sustainable agricultural systems for people everywhere. Science with Service Delivering Success®.
DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders, we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.
Forward-Looking Statements: This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control. Some of the important factors that could cause the company’s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting products based on biotechnology and, in general, for products for the agriculture industry; outcome of significant litigation and environmental matters, including realization of associated indemnification assets, if any; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could affect demand as well as availability of products for the agriculture industry; ability to protect and enforce the company’s intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses; and risks related to the agreement entered on December 11, 2015, with The Dow Chemical Company pursuant to which the companies have agreed to effect an all-stock merger of equals, including the completion of the proposed transaction on anticipated terms and timing, the ability to fully and timely realize the expected benefits of the proposed transaction and risks related to the intended business separations contemplated to occur after the completion of the proposed transaction. The company undertakes no duty to publicly revise or update any forward-looking statements as a result of future developments, or new information or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.